Chernukha Sergey Nikolaevich (Candidate of Medical Sciences, Institute «Medical Academy named after S.I. Georgievsky» Federal State Autonomous Educational Institution of Higher Education «Crimean Federal University named after V.I. Vernadsky», Simferopol)
Viltsaniuk Irina Aleksandrovna (Candidate of Medical Sciences, Associate Professor, Institute «Medical Academy named after S.I. Georgievsky» Federal State Autonomous Educational Institution of Higher Education «Crimean Federal University named after V.I. Vernadsky», Simferopol)
| |
To study the eradication effectiveness of one–week four-component concomitant therapy without colloidal bismuth, depending on the choice of a proton pump inhibitor - esomeprazole or pantoprazole, the results of treatment of 132 patients with newly diagnosed H. pylori infection aged 21 to 59 years with verified peptic ulcers (and chronic gastritis) were analyzed. The main group included 68 patients, who received 7-day four-component concomitant therapy without colloidal bismuth: esomeprazole 40 mg twice a day, amoxicillin 1 g twice a day, metronidazole 500 mg twice a day, and clarithromycin 500 mg twice a day for 7 days, and in the control group, 64 patients received a similar antimicrobial regimen, but pantoprazole 40 mg twice a day was prescribed as acid suppression. The eradication effectiveness of the four-component concomitant one-week regimen in the main group, including esomeprazole, amoxicillin, clarithromycin and metronidazole was 91.2%, which is unreliably higher (p>0.05) than the results obtained during the treatment with the eradication regimen in the control group using pantoprazole (82.8%). Concomitant four-component, one-week, non- bismuth therapy allows for a high percentage of eradication as a first-line regimen, both due to a combination of antimicrobial drugs and due to the effective suppression of gastric acidity of esomeprazole, as well as avoiding a large number of side effects.
Keywords:Helicobacter pylori, esomeprazole, pantoprazole, antihelicobacter therapy, eradication.
|
|
| |
|
Read the full article …
|
Citation link:
Chernukha S. N., Viltsaniuk I. A. Comparative evaluation of the concomitant four-component antihelicobacter therapy eradication effectiveness // Современная наука: актуальные проблемы теории и практики. Серия: Естественные и Технические Науки. -2022. -№04. -С. 248-252 DOI 10.37882/2223-2966.2022.04.37 |
|
|
